Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Bayer AG
  6. News
  7. Summary
    BAYN   DE000BAY0017

BAYER AG

(BAYN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Uni?o Qu?mica Farmac?utica Nacional S.A. completed the acquisition of Cancioneiro Plant in Sao Paulo from Bayer Aktiengesellschaft for approximately $110 million.

11/19/2021 EST

Uni?o Qu?mica Farmac?utica Nacional S.A. bound an agreement to acquire Cancioneiro Plant in Sao Paulo from Bayer Aktiengesellschaft (XTRA:BAYN) on March 23, 2021. Uni?o Qu?mica Farmac?utica Nacional S.A. completed the acquisition of Cancioneiro Plant in Sao Paulo from Bayer Aktiengesellschaft (XTRA:BAYN) for approximately $110 million on November 19, 2021. Transaction is financed through Uni?o Qu?mica's cash flow and the issuance of debentures. The transaction is approved by the antitrust body Cade without restrictions.


© S&P Capital IQ 2021
All news about BAYER AG
01/21MustGrow Biologics Up 7.6% after Reporting Exclusive Agreement with Bayer
MT
01/19BlueRock Therapeutics Announces First Patient Dosed in Canada in Phase 1 Trial in Patie..
AQ
01/17Factbox-GSK's consumer healthcare business coveted by Unilever
RE
01/17BAYER : Annual Bayer Pharma Media Day 2022
PU
01/15Factbox-GSK's consumer health business
RE
01/12BAYER AG : JP Morgan keeps its Buy rating
MD
01/11Netafim USA and Bayer Partners to Launch the “Precise Defense” Crop Protectio..
CI
01/10Correction to Bayer Gene Editing Article
DJ
01/10Bayer to Collaborate on Gene Editing Technology With Mammoth Biosciences
DJ
01/10Bayer in gene therapy collaboration with Mammoth Biosciences
RE
More news
Analyst Recommendations on BAYER AG
More recommendations
Financials
Sales 2021 43 078 M 48 342 M 48 342 M
Net income 2021 459 M 515 M 515 M
Net Debt 2021 37 821 M 42 443 M 42 443 M
P/E ratio 2021 81,8x
Yield 2021 3,97%
Capitalization 50 644 M 57 141 M 56 833 M
EV / Sales 2021 2,05x
EV / Sales 2022 1,94x
Nbr of Employees 99 814
Free-Float 100,0%
Chart BAYER AG
Duration : Period :
Bayer AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER AG
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Last Close Price 51,55 €
Average target price 64,23 €
Spread / Average Target 24,6%
EPS Revisions
Managers and Directors
Werner Baumann Chairman-Management Board & CEO
Wolfgang U. Nickl Chief Financial Officer
Norbert Winkeljohann Chairman-Supervisory Board
Bijoy Sagar Chief Information Technology Officer
Paul Achleitner Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BAYER AG9.68%56 319
JOHNSON & JOHNSON-2.01%441 302
ROCHE HOLDING AG-8.68%304 745
PFIZER, INC.-11.02%294 900
ABBVIE INC.-1.71%235 287
ELI LILLY AND COMPANY-13.31%217 093